Seer, Inc. (SEER) Stock Score, Valuation & Financial Research
Seer, Inc. is in the Healthcare sector and Biotechnology industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 32/100.
Quick answer for SEER
Seer, Inc. currently has a Wall Street Score of 32/100. The stored market price is $1.9. Its financial score is 26/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Seer, Inc. does
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery L
SEER financial snapshot
- Wall Street Score:
- 32/100
- Current price:
- $1.9
- Market capitalization:
- $104.5M
- Revenue:
- $14.7M
- Net income:
- $-70.5M
- Free cash flow:
- $-46.2M
- Cash:
- $47.3M
- Total debt:
- $23.0M
- EPS:
- -1.28
- Financial score:
- 26/100
- Valuation score:
- 0/100
- Revenue score:
- 4/100
What stands out
- Reported year-over-year revenue growth is -0.1%.
- Free cash flow is $-46.2M, showing cash burn in the current stored period.
- The balance sheet shows $47.3M of cash versus $23.0M of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 26/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research SEER
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.